| Therapeutic combinations comprising anti-FOLR1 immunoconjugates |
2023-9-22 |
2023-10-12 |
|
| Diagnostic assays and kits for detection of folate receptor 1 |
2023-8-04 |
2023-8-31 |
|
| Methods of preventing methionine oxidation in immunoconjugates |
2023-7-18 |
2023-9-01 |
|
| Preparation of maytansinoid antibody conjugates by one-step process |
2023-4-21 |
2023-6-15 |
|
| Methods of preparing cytotoxic benzodiazepine derivatives |
2023-4-11 |
2023-5-04 |
|
| Antibodies and assays for detection of folate receptor 1 |
2023-3-30 |
2023-6-01 |
|
| Conjugation methods |
2023-2-28 |
2023-5-30 |
|
| Methods of preparing cytotoxic benzodiazepine derivatives |
2023-1-19 |
2023-9-14 |
|
| Anti-cd 123 antibodies and conjugates and derivatives thereof |
2022-12-27 |
2023-3-14 |
|
| Cross-linkers and their uses |
2022-12-27 |
2023-3-14 |
|
| Selective sulfonation of benzodiazepine derivatives |
2022-12-26 |
2023-3-14 |
|
| Methods of treatment using anti-cd123 immunoconjugates |
2022-11-09 |
2023-10-05 |
|
| Methods of preparing indolinobenzodiazepine derivatives |
2022-10-31 |
2023-1-31 |
|
| Folate receptor 1 antibodies and immunoconjugates and uses thereof |
2022-10-26 |
2022-12-27 |
|
| Cytotoxic benzodiazepine derivatives |
2022-10-25 |
2023-7-27 |
|
| Cd37-binding molecules immunoconjugates thereof |
2022-10-07 |
2023-9-14 |
|
| Process for preparing purified drug conjugates |
2022-9-08 |
2023-5-25 |
|
| Conjugates of cysteine engineered antibodies |
2022-8-15 |
2022-10-25 |
|
| Improved methods for preparing cytotoxic benzodiazepine derivatives |
2022-8-12 |
2023-6-01 |
|
| Folate receptor 1 antibodies and immunoconjugates and uses thereof |
2022-8-03 |
2022-9-15 |
|
| Anti-cd37 immunoconjugate and anti-cd20 antibody combinations |
2022-7-25 |
2023-6-22 |
|
| Maytansinoid derivatives with self-immolative peptide linkers and conjugates … |
2022-7-13 |
2022-9-21 |
|
| Methods of preparing cytotoxic benzodiazepine derivatives |
2022-6-15 |
2023-2-09 |
|
| Methods of preparing cytotoxic benzodiazepine derivatives |
2022-6-15 |
2023-2-09 |
|
| Biparatopic fr-alpha antibodies and immunoconjugates |
2022-6-10 |
2023-3-23 |
|
| Treatment of cancer in patients with soluble fr-alpha |
2022-6-02 |
2023-4-13 |
|
| Cytotoxic benzodiazepine derivatives, compositions comprising the same and uses … |
2022-5-25 |
2022-7-01 |
|
| Anti-FOLR1 Immunoconjugate Dosing Regimens |
2022-4-14 |
2022-12-01 |
|
| Process for preparing purified drug conjugates |
2022-3-28 |
2022-4-14 |
|
| Methods for increasing efficacy of immunoconjugates targeting adam9 for the … |
2022-3-07 |
2022-9-15 |
|
| Improved methods for the acylation of maytansinol |
2022-3-07 |
2022-3-31 |
|
| Conjugation methods |
2022-2-24 |
2022-3-17 |
|
| Method of targeting specific cell populations using cell-binding agent … |
2022-2-18 |
2022-5-09 |
|
| Methods for increasing efficacy of folr1 cancer therapy |
2022-2-10 |
2022-4-19 |
|
| Methods for antibody drug conjugation, purification, and formulation |
2022-2-08 |
2022-8-25 |
|
| Methods for formulating antibody drug conjugate compositions |
2022-1-26 |
2022-3-30 |
|
| Therapeutic combinations comprising anti-cd123 immunoconjugates |
2021-10-20 |
2021-12-01 |
|
| Camptothecin derivatives |
2021-10-15 |
2022-5-05 |
|
| Methods of preparing cell-binding agent-drug conjugates |
2021-9-22 |
2021-10-31 |
|
| Anti-folr1 immunoconjugate dosing regimens |
2021-7-30 |
2021-11-18 |
|
| Cytotoxic benzodiazepine derivatives |
2021-7-24 |
2021-8-19 |
|
| Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations |
2021-7-21 |
2022-5-26 |
|
| Novel benzodiazepine derivatives |
2021-6-25 |
2021-9-23 |
|
| Pharmaceutical formulations and methods of use thereof |
2021-4-28 |
2021-8-12 |
|
| Epcam antibodies, activatable antibodies, and immunoconjugates, and uses … |
2021-4-20 |
2021-6-30 |
|
| Cross-linkers and their uses |
2021-4-01 |
2023-8-10 |
2023-8-10 |
| IMPROVED CYTOTOXIC AGENTS CONTAINING NOVEL MAYTANSINOIDS |
2021-3-26 |
2021-10-29 |
|
| Conjugates comprising cell-binding agents and cytotoxic agents |
2021-2-12 |
2021-9-30 |
|
| Compositions and methods for antibody production |
2021-1-13 |
2021-5-06 |
|
| Methods for increasing efficacy of folr1 cancer therapy. |
2021-1-08 |
2022-7-11 |
|
| Novel benzodiazepine derivatives |
2021-1-07 |
2021-8-05 |
|
| Diagnostic assays and kits for detection of folate receptor 1. |
2021-1-07 |
2022-7-08 |
|
| Immunoconjugates targeting adam9 and methods of use thereof |
2020-12-21 |
2021-3-01 |
|
| ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF |
2020-9-14 |
2022-1-26 |
|
| Cytotoxic benzodiazepine derivatives |
2020-8-18 |
2020-11-13 |
|
| Nucleic acid molecules with improved stability and uses thereof |
2020-6-26 |
2023-5-12 |
|
| FOLATE RECEPTOR 1 ANTIBODIES AND IMMUNOCONJUGATES AND THEIR USES |
2020-4-22 |
2022-8-31 |
|
| Cytotoxic bis-benzodiazepine derivatives and cell binding agents and conjugates … |
2020-3-27 |
2022-1-25 |
|
| Methods for detection of folate receptor 1 in a patient sample |
2020-2-23 |
2020-4-30 |
|
| Separation of triple-light chain antibodies using cation exchange … |
2020-2-23 |
2020-4-30 |
|
| Cd37-binding molecules and immunoconjugates thereof |
2020-2-10 |
2020-8-27 |
|
| Use of pvdf membrane to purify cell-binding agent cytotoxic agent conjugates |
2020-2-07 |
2020-5-28 |
|
| Methods of preparing cytotoxic benzodiazepine derivatives |
2019-12-20 |
2020-3-20 |
|
| Process for preparing cell-binding agent-cytotoxic agent conjugates |
2019-8-07 |
2020-4-02 |
|
| Met antibodies and immunoconjugates and uses thereof |
2019-7-10 |
2020-1-16 |
|
| IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE OF THEM |
2019-6-25 |
2021-2-10 |
|
| Combination treatment with antibody-drug conjugates and flt3 inhibitors |
2019-5-14 |
2019-12-19 |
|
| Combination treatment with antibody-drug conjugates and parp inhibitors |
2019-5-01 |
2019-6-30 |
|
| Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
2019-2-19 |
2020-2-13 |
|
| METHOD FOR THE PREPARATION OF PURIFIED ANSAMITOKINES |
2019-2-13 |
2020-5-29 |
|
| Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of … |
2018-12-27 |
2023-10-24 |
2023-10-24 |
| Benzodiazepine derivatives |
2018-12-27 |
2020-11-04 |
|
| Gcc-targeted antibody-drug conjugates |
2018-12-25 |
2019-10-18 |
|
| Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents |
2018-12-20 |
2019-4-18 |
|
| METHOD FOR THE MANUFACTURE OF CHARGED INTERCONNECTORS |
2018-12-10 |
2019-12-11 |
|
| Combination treatment with antibody-drug conjugates and cytarabine |
2018-10-30 |
2020-3-05 |
|
| Uses of immunoconjugates targeting cd138 |
2018-9-24 |
2019-4-25 |
|
| Benzodiazepines and conjugates thereof |
2018-7-09 |
2019-3-07 |
|
| Anti-cd33 immunoconjugate dosing regimens |
2018-5-16 |
2021-6-16 |
|
| Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using … |
2018-5-14 |
2018-12-20 |
|
| Cytotoxic benzodiazepine derivatives and conjugates thereof |
2018-4-19 |
2018-10-25 |
|
| Drug conjugate composition |
2018-4-02 |
2019-1-10 |
|
| Cd19-targeting antibody-drug conjugates |
2018-3-28 |
2018-12-27 |
|